Carna Biosciences (TSE:4572) Inventories, Work In Process: 円11.6 Mil (As of Dec. 2025)


TSE:4572 Carna Biosciences Inc TSE:4572
29 GF Score
Price 円314.00
GF Value 円175.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Inventories, Work In Process?

Carna Biosciences TSE:4572 -3.68% 29 Inventories, Work In Process is 円11.6 Mil as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 29/100 and a GF Value™ of 円175.60 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Carna Biosciences's work in process for the quarter that ended in Dec. 2025 was 円11.6 Mil.

Carna Biosciences Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Inventories, Work In Process Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.52 5.92 12.39 9.07 11.61

Carna Biosciences Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.07 12.68 13.99 11.61 13.24
TSE:4572
29GF Score
Carna Biosciences Inc TSE:4572
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of 円11.6 Mil mean?
Carna Biosciences (TSE:4572) has a Inventories, Work In Process of 円11.6 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Carna Biosciences and its competitors.
Is Carna Biosciences' Inventories, Work In Process too high?
Carna Biosciences' current Inventories, Work In Process is 円11.6 Mil. Overall, Carna Biosciences has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Inventories, Work In Process compare to VRTX and REGN?
Carna Biosciences' Inventories, Work In Process of 円11.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Inventories, Work In Process is 円11.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円175.60, compared to a current price of 円314.00 — trading 78.8% above its estimated fair value. The current Inventories, Work In Process is 円11.6 Mil. Carna Biosciences' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Inventories, Work In Process is 円11.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円314.00 is trading 78.8% above its estimated GF Value™ of 円175.60. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Inventories, Work In Process: 円11.6 Mil
  • GF Value™: 円175.60 vs. price of 円314.00 (78.8% above fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
29GF Score

Get the complete analysis for TSE:4572

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円314.00
Price
円175.60
GF Value